Lung transplant outcomes: A review of survival, graft function, physiology, health-related quality of life and cost-effectiveness

European Respiratory Journal

Volumn 24, Issue 4, 2004, Pages 674-685

  Studer, S M ^a   Levy, R D ^c   McNeil, K ^d   Orens, Jorens B ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c ST PAUL S HOSPITAL   (Canada)

^d School of Medicine   (Canada)

Author keywords

Cost; Function; Lung transplantation; Outcomes; Quality of life; Survival

Indexed keywords

CALCINEURIN INHIBITOR; LIPID; STEROID;

ADRENAL DISEASE; BODY WEIGHT DISORDER; BREATHING MECHANICS; BRONCHIOLITIS; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST EFFECTIVENESS ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; EXERCISE; FORCED EXPIRATORY VOLUME; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HEART LUNG TRANSPLANTATION; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY DISEASE; LUNG FIBROSIS; LUNG FUNCTION; LUNG INSUFFICIENCY; LUNG TRANSPLANTATION; LYMPHOMA; MORBIDITY; MORTALITY; NEUROLOGIC DISEASE; OSTEOPOROSIS; PATIENT CARE; PATIENT MONITORING; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUALITY OF LIFE; RECIPIENT; REVIEW; SKIN CANCER; SURGICAL TECHNIQUE; TREATMENT OUTCOME; WEIGHT GAIN;

COST-BENEFIT ANALYSIS; GRAFT SURVIVAL; HUMANS; LUNG TRANSPLANTATION; QUALITY OF LIFE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0242641801     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00065004     Document Type: Review

References (101)

1. www.ustransplant.org/csr0704/nat-sum.php?organ=IN&table=html& submit=GO. Date last accessed: June 1, 2004.
2. Herve P, Silbert D, Cerrina J, Simonneau G, Dartevelle P. Impairment of bronchial mucociliary clearance in long-term survivors of heart/lung and double-lung transplantation. The Paris-Sud Lung Transplant Group. Chest 1993; 103: 59-63.
3. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The registry of the International Society for Heart and Lung Transplantation: eighteenth official report-2001. J Heart Lung Transplant 2001; 20: 805-815.
4. Meyer DM, Bennett LE, Novick RJ, Hosenpud JD. Single versus bilateral, sequential lung transplantation for end-stage emphysema influence of recipient age on survival and secondary end-points. J Heart Lung Transplant 2001; 20: 935-941.
5. Cassivi SD, Meyers BF, Battafarano RJ, et al. Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg 2002; 74: 1663-1669.
6. Hadjiliadis D, Davis RD, Palmer SM. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients? Chest 2002; 122: 1168-1175.
7. Waddell TK, Bennett L, Kennedy R, Todd TR, Keshavjee SH. Heart-lung or lung transplantation for Eisenmenger syndrome. J Heart Lung Transplant 2002; 21: 731-737.
8. McGregor CG, Jamieson SW, Baldwin JC, et al. Combined heart-lung transplantation for end-stage Eisenmenger's syndrome. J Thorac Cardiovasc Surg 1986; 91: 443-450.
9. Bando K, Armitage JM, Paradis IL, et al. Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg 1994; 108: 1056-1065.
10. Ueno T, Smith JA, Snell GI, et al. Bilateral sequential single lung transplantation for pulmonary hypertension and Eisenmenger's syndrome. Ann Thorac Surg 2000; 69: 381-387.
11. Stoica SC, McNeil KD, Perreas K, et al. Heart-lung transplantation for Eisenmenger syndrome: early and long-term results. Ann Thorac Surg 2001; 72: 1887-1891.
12. Conte JV, Borja MJ, Patel CB, Yang SC, Jhaveri RM, Orens JB. Lung transplantation for primary and secondary pulmonary hypertension. Ann Thorac Surg 2001; 72: 1673-1679.
13. Meyer DM, Bennett LE, Novick RJ, Hosenpud JD. Effect of donor age and ischemic time in intermediate survival and morbidity after lung transplantation. Chest 2000; 118: 1255-1262.
14. Heng D, Sharples LD, McNeil K, Stewart S, Wreghitt T, Wallwork J. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant 1998; 17: 1255-1263.
15. De Meester J, Smits JM, Persijn GG, Haverich A. Lung transplant waiting list: differential outcome of type of end-stage lung disease, one year after registration. J Heart Lung Transplant 1999; 18: 563-571.
16. Hosenpud JD, Bennett LE, Keck BM, Edwards E, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998; 35: 24-27.
17. Hertz MI, Taylor DO, Trulock EP, et al. The registry of the international society for heart and lung transplantation: nineteenth official report-2002. J Heart Lung Transplant 2002; 21: 950-970.
18. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297-310.
19. Negri J, Dunning J, Sharples LD, McNeil K. Native lung volume reduction following single lung transplantation for emphysema. J Heart Lung Transplant 2001; 20: 177 (abstract).
20. Smith S, Foweraker J, Hamilton D, White J, McNeil K. Impact of antibiotic resistant pseudomonas on the survival of cystic fibrosis patients following heart-lung transplantation. J Heart Lung Transplant 2001; 20: 224 (abstract).
21. Collins J, Hartman MJ, Warner TF, et al. Frequency and CT findings of recurrent disease after lung transplantation. Radiology 2001; 219: 503-509.
22. Schulman LL, Estenne M. Effects of transplantation on lung and exercise physiology. Eur Respir Monograph 2004 (in press).
23. Banner NR, Heaton R, Hollingshead L, Guz A, Yacoub MH. Bronchial reactivity to methacholine after combined heart-lung transplantation. Thorax 1988; 43: 955-959.
24. Glanville AR, Yeend RA, Theodore J, Robin ED. Effect of single respiratory manoeuvres on specific airway conductance in heart-lung transplant recipients. Clin Sci (Lond) 1988; 74: 311-317.
25. Glanville AR, Theodore J, Baldwin JC, Robin ED. Bronchial responsiveness after human heart-lung transplantation. Chest 1990; 97: 1360-1366.
26. Maurer JR, McLean PA, Cooper JD, Chamberlain DW, Grossman RF, Zamel N. Airway hyperreactivity in patients undergoing lung and heart/lung transplantation. Am Rev Respir Dis 1989; 139: 1038-1041.
27. Higenbottam T, Jackson M, Rashdi T, Stewart S, Coutts C, Wallwork J. Lung rejection and bronchial hyperresponsiveness to methacholine and ultrasonically nebulized distilled water in heart-lung transplantation patients. Am Rev Respir Dis 1989; 140: 52-57.
28. Higenbottam T, Jackson M, Woolman P, Lowry R, Wallwork J. The cough response to ultrasonically nebulized distilled water in heart-lung transplantation patients. Am Rev Respir Dis 1989; 140: 58-61.
29. Sanders MH, Owens GR, Sciurba FC, et al. Ventilation and breathing pattern during progressive hypercapnia and hypoxia after human heart-lung transplantation. Am Rev Respir Dis 1989; 140: 38-44.
30. Shea SA, Horner RL, Banner NR, et al. The effect of human heart-lung transplantation upon breathing at rest and during sleep. Respir Physiol 1988; 72: 131-149.
31. Duncan SR, Kagawa FT, Starnes VA, Theodore J. Hypercarbic ventilatory responses of human heart-lung transplant recipients. Am Rev Respir Dis 1991; 144: 126-130.
32. Kimoff RJ, Cheong TH, Cosio MG, Guerraty A, Levy RD. Pulmonary denervation in humans. Effects on dyspnoea and ventilatory pattern during exercise. Am Rev Respir Dis 1990; 142: 1034-1040.
33. Sanders MH, Costantino JP, Owens GR, et al. Breathing during wakefulness and sleep after human heart-lung transplantation. Am Rev Respir Dis 1989; 140: 45-51.
34. Otulana BA, Higenbottam TW, Scott JP, Wallwork J. A possible role for mixed venous blood changes in the hyperventilation of exercise in heart-lung transplant recipients. Chest 1990; 97: 3 Suppl., 88S-89S.
35. Estenne M, Primo G, Yernault JC. Cardiorespiratory responses to dynamic exercise after human heart-lung transplantation. Thorax 1987; 42: 629-630.
36. Robin ED, Theodore J, Burke CM, et al. Hypoxic pulmonary vasoconstriction persists in the human transplanted lung. Clin Sci (Lond) 1987; 72: 283-287.
37. Theodore J, Morris AJ, Burke CM, et al. Cardiopulmonary function at maximum tolerable constant work rate exercise following human heart-lung transplantation. Chest 1987; 92: 433-439.
38. Lisbona R, Hakim TS, Dean GW, Langleben D, Guerraty A, Levy RD. Regional pulmonary perfusion following human heart-lung transplantation. J Nucl Med 1989; 30: 1297-1301.
39. Gibbons WJ, Levine SM, Bryan CL, et al. Cardiopulmonary exercise responses after single lung transplantation for severe obstructive lung disease. Chest 1991; 100: 106-111.
40. Grossman RF, Frost A, Zamel N, et al. Results of single-lung transplantation for bilateral pulmonary fibrosis. The Toronto Lung Transplant Group. N Engl J Med 1990; 322: 727-733.
41. Levine SM, Jenkinson SG, Bryan CL, et al. Ventilation-perfusion inequalities during graft rejection in patients undergoing single lung transplantation for primary pulmonary hypertension. Chest 1992; 101: 401-405.
42. Glanville AR, Theodore J, Harvey J, Robin ED. Elastic behaviour of the transplanted lung. Exponential analysis of static pressure-volume relationships. Am Rev Respir Dis 1988; 137: 308-312.
43. Theodore J, Jamieson SW, Burke CM, et al. Physiologic aspects of human heart-lung transplantation. Pulmonary function status of the post-transplanted lung. Chest 1984; 86: 349-357.
44. Otulana BA, Higenbottam TW, Wallwork J. Causes of exercise limitation after heart-lung transplantation. J Heart Lung Transplant 1992; 11: Suppl. 4, S244-S251.
45. Williams TJ, Grossman RF, Maurer JR. Long-term functional follow-up of lung transplant recipients. Clin Chest Med 1990; 11: 347-358.
46. Levy RD, Ernst P, Levine SM, et al. Exercise performance after lung transplantation. J Heart Lung Transplant 1993; 12: Suppl. 1, 27-33.
47. Williams TJ, Patterson GA, McClean PA, Zamel N, Maurer JR. Maximal exercise testing in single and double lung transplant recipients. Am Rev Respir Dis 1992; 145: 101-105.
48. Miyoshi S, Trulock EP, Schaefers HJ, Hsieh CM, Patterson GA, Cooper JD. Cardiopulmonary exercise testing after single and double lung transplantation. Chest 1990; 97: 1130-1136.
49. Glanville AR, Burke CM, Theodore J, et al. Bronchial hyper-responsiveness after human cardiopulmonary transplantation. Clin Sci (Lond) 1987; 73: 299-303.
50. Glanville AR, Gabb GM, Theodore J, Robin ED. Bronchial responsiveness to exercise after human cardiopulmonary transplantation. Chest 1989; 96: 281-286.
51. Herve P, Picard N, Le Roy LM, et al. Lack of bronchial hyperresponsiveness to methacholine and to isocapnic dry air hyperventilation in heart/lung and double-lung transplant recipients with normal lung histology. The Paris-Sud Lung Transplant Group. Am Rev Respir Dis 1992; 145: 1503-1505.
52. Rajagopalan N, Maurer J, Kesten S. Bronchodilator response at low lung volumes predicts bronchiolitis obliterans in lung transplant recipients. Chest 1996; 109: 405-407.
53. Guz A, Noble M, Eisele J, Trenchard D. Experimental results of vagal block in cardiopulmonary disease. In: Porter R, ed. Breathing: Hering-Breuer Centenary Symposium. London, Churchill, 1970; pp. 315-329.
54. Davies SF, McQuaid KR, Iber C, et al. Extreme dyspnoea from unilateral pulmonary venous obstruction. Demonstration of a vagal mechanism and relief by right vagotomy. Am Rev Respir Dis 1987; 136: 184-188.
55. Berglund E, Furhoff AK, Lofstrom B, Oquist L. A study of the effects of unilateral vagus nerve block in a dyspnoeic patient. Scand J Respir Dis 1971; 52: 34-38.
56. Winning AJ, Hamilton RD, Shea SA, Knott C, Guz A. The effect of airway anaesthesia on the control of breathing and the sensation of breathlessness in man. Clin Sci (Lond) 1985; 68: 215-225.
57. Altose MD. Assessment and management of breathlessness. Chest 1985; 88: Suppl. 2, 77S-83S.
58. Banner NR, Lloyd MH, Hamilton RD, Innes JA, Guz A, Yacoub MH. Cardiopulmonary response to dynamic exercise after heart and combined heart-lung transplantation. Br Heart J 1989; 61: 215-223.
59. Tapper DP, Duncan SR, Kraft S, Kagawa FT, Marshall S, Theodore J. Detection of inspiratory resistive loads by heart-lung transplant recipients. Am Rev Respir Dis 1992; 145: Suppl. 2, 458-460.
60. Noirclerc M, Shennib H, Giudicelli R, et al. Size matching in lung transplantation. J Heart Lung Transplant 1992; 11: Suppl. 4, S203-S208.
61. Otulana BA, Mist BA, Scott JP, Wallwork J, Higenbottam T. The effect of recipient lung size on lung physiology after heart-lung transplantation. Transplantation 1989; 48: 625-629.
62. Lloyd KS, Barnard P, Holland VA, Noon GP, Lawrence EC. Pulmonary function after heart-lung transplantation using larger donor organs. Am Rev Respir Dis 1990; 142: 1026-1029.
63. Trulock EP, Cooper JD, Kaiser LR, Pasque MK, Ettinger NA, Dresler CM. The Washington University-Barnes Hospital experience with lung transplantation. Washington University Lung Transplantation Group. JAMA 1991; 266: 1943-1946.
64. Mal H, Sleiman C, Jebrak G, et al. Functional results of single-lung tranplantation for chronic obstructive lung disease. Am J Respir Crit Care Med 1994; 149: 1476-1481.
65. Orens J, Martinez F, Becker F, Deeb M, Christensen P, Lynch J. Cardiopulmonary exercise testing following allogeneic lung transplantation for different underlying disease states. Chest 1995; 107: 144-149.
66. Patterson GA, Maurer JR, Williams TJ, Cardoso P, Scavuzzo M, Todd T. Comparison of outcomes of double and single lung transplantation for obstructive lung disease. J Thorac Cardiovasc Surg 1991; 101: 623-632.
67. Bando K, Paradis I, Keenan RJ, et al. Comparison of coutcomes after single and bilateral lung transplantation for obstructive lung disease. J Heart Lung Transplant 1995; 14: 692-698.
68. Levine SM, Anzueto A, Gibbons WJ, et al. Graft position and pulmonary function after single lung transplantation for obstructive lung disease. Chest 1993; 103: 444-448.
69. Williams TJ, Grossman RF, Maurer JR. Long-term functional follow-up of lung transplant recipients. Clin Chest Med 1990; 11: 347-358.
70. Evans AB, Al Himyary AJ, Hrovat MI, et al. Abnormal skeletal muscle oxidative capacity after lung transplantation by 31P-MRS. Am J Respir Crit Care Med 1997; 155: 615-621.
71. Lands LC, Smountas AA, Mesiano G, et al. Maximal exercise capacity and peripheral skeletal muscle function following lung transplantation. J Heart Lung Transplant 1999; 18: 113-120.
72. Sciurba FC, Owens GR, Sanders MH, Costantino JP, Paradis IL, Griffith BP. The effect of obliterative bronchiolitis on breathing pattern during exercise in recipients of heart-lung transplants. Am Rev Respir Dis 1991; 144: 131-135.
73. Bloomfield SA. Changes in musculoskeletal structure and function with prolonged bed rest. Med Sci Sports Exerc 1997; 29: 197-206.
74. Wang XN, Williams TJ, McKenna MJ, et al. Skeletal muscle oxidative capacity, fiber type, and metabolites after lung transplantation. Am J Respir Crit Care Med 1999; 52 (abstract).
75. Morton JM, McKenna MJ, Carey MF, et al. Reduction sin type I fibre proportions and oxidative enzyme activity in skeletal muscle exist pre- and post-lung transplantation. J Heart Lung Transplant 1999; 160: 57-63.
76. Tirdel GB, Girgis R, Fishman RS, Theodore J. Metabolic myopathy as a cause of the exercise limitation in lung transplant recipients. J Heart Lung Transplant 1998; 17: 1231-1237.
77. Oelberg DA, Systrom DM, Markowitz DH, et al. Exercise performance in cystic fibrosis before and after bilateral lung transplantation. J Heart Lung Transplant 1998; 17: 1104-1112.
78. Systrom DM, Pappagianopoulos P, Fishman RS, Wain JC, Girms LC. Determinants of abnormal maximum oxygen uptake after lung transplantation for chronic obstructive pulmonary disease. J Heart Lung Transplant 1998; 17: 1220-1230.
79. Sinoway LI, Minotti JR, Davis D, et al. Delayed reversal of impaired vasodilation in congestive heart failure after heart transplantation. Am J Cardiol 1988; 61: 1076-1079.
80. Hokanson JF, Mercier JG, Brooks GA. Cyclosporine A decreases rat skeletal muscle mitochondrial respiration in vitro. Am J Respir Crit Care Med 1995; 151: 1848-1851.
81. Mercier JG, Hokanson JF, Brooks GA. Effects of cyclosporine A on skeletal muscle mitochondrial respiration and endurance time in rats. Am J Respir Crit Care Med 1995; 151: 1532-1536.
82. Decramer M, de BV, Dom R. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 6 Pt 1: 1958-1964.
83. Kavanagh T, Yacoub MH, Mertens DJ, Kennedy J, Campbell RB, Sawyer P. Cardiorespiratory responses to exercise training after orthotopic cardiac transplantation. Circulation 1988; 77: 162-171.
84. Kempeneers G, Noakes TD, Zyl-Smit R, et al. Skeletal muscle limits the exercise tolerance of renal transplant recipients: effects of a graded exercise training program. Am J Kidney Dis 1990; 16: 57-65.
85. Stephenson AL, Yoshida EM, Abboud RA, Fradet G, Levy RD. Impaired exercise performance following successful liver transplantation. Transplantation 2001; 72: 1161-1164.
86. Casaburi R, Patessio A, Ioli F, Zanaboni S, Donner CF, Wasserman K. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis 1991; 143: 9-18.
87. Maltais F, LeBlanc P, Jobin J, et al. Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 155: 555-561.
88. Maltais F, LeBlanc P, Simard C, et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: Suppl. 2, 442-447.
89. Stiebellehner L, Quittan M, End A, et al. Aerobic endurance training program improves exercise performance in lung transplant recipients. Chest 1998; 113: 906-912.
90. Ambrosino N, Bruschi C, Callegari G, et al. Time course of exercise capacity, skeletal and respiratory muscle performance after heart-lung transplantation. Eur Respir J 1996; 9: 1508-1514.
91. Ramsey SD, Patrick DL, Lewis S, Albert RK, Raghu G. Improvement in quality of life after lung transplantation: a preliminary study. The University of Washington Medical Center Lung Transplant Study Group. J Heart Lung Transplant 1995; 14: 870-877.
92. Gross C, Savik K, Bolman M, Hertz MI. Long-term health status and quality-of-life outcomes of lung transplant recipients. Chest 1995; 108: 1587-1593.
93. TenVergert EM, Essink-Bot ML, Geertsma A, van Enckevort PJ, de Boer WJ, van der BW. The effect of lung transplantation on health-related quality of life: a longitudinal study. Chest 1998; 113: 358-364.
94. van Den Berg JW, Geertsma A, van Der BIJ, et al. Bronchiolitis obliterans syndrome after lung transplantation and health-related quality of life. Am J Respir Crit Care Med 2000; 161: 1937-1941.
95. Anyanwu AC, McGuire A, Rogers CA, Murday AJ. Assessment of quality of life in lung transplantation using a simple generic tool. Thorax 2001; 56: 218-222.
96. Gross CR, Raghu G. The cost of lung transplantation and the quality of life post-transplant. Clin Chest Med 1997; 18: 391-403.
97. Lanuza DM, Lefaiver C, Mc CM, Farcas GA, Garrity E Jr. Prospective study of functional status and quality of life before and after lung transplantation. Chest 2000; 118: 115-122.
98. Ramsey S, Patrick D, Albert R, Larson E, Wood D, Raghu G. The cost effectiveness of lung transplantation. Chest 1995; 108: 1594-1601.
99. Gartner SH, Sevick MA, Keenan RJ, Chen GJ. Cost-utility of lung transplantation: a pilot study. J Heart Lung Transplant 1997; 16: 1129-1134.
100. van Enckevort PJ, Koopmanschap MA, TenVergert EM, et al. Lifetime costs of lung transplantation: estimation of incremental costs. Health Econ 1997; 6: 479-489.
101. Anyanwu AC, McGuire A, Rogers CA, Murday AJ. An economic evaluation of lung transplantation. J Thorac Cardiovasc Surg 2002; 123: 411-418.